Henry J. Riordan and Neal R. Cutler at Worldwide Clinical Trials discuss how the biomarkers can aid in the development of novel therapeutic agents by supporting patie...

Operational efficiency is critical for an organisation that develops pioneering new cancer treatments for patients. Relying on manual processes and legacy systems to ...

Ensuring you have instant access to your clinical trial data is stressful – you need to invest in smart e-solutions, train your teams in system use, ensure they work ...

The Impact of Technology on the Management and Outcome of Patients Matt Weisensee at CRF Health and Sharon Tracy at Health Care Strategy will discuss in this article ...

Florence Barkats at Cisiv Ltd., Tigran Arzumanov at Clinerion Ltd. and Le Vin Chin at Clinerion Ltd. are talking about how the integration of solutions for querying p...

Journal for Clinical Studies talks to Jeff Lee, CEO at mProve Health about why a BYOD approach is proving to be a welcome option for today’s sponsors and CROs, and th...

The differences and advantages of both data warehouses and data lakes are frequently being debated. Is the data warehouse obsolete? Will the data lake replace the dat...

Clinical trials continue to increase in complexity and scope. A typical Phase III protocol, for example, now has many more endpoints, procedures, and data points coll...

The pharmaceutical industry continues to face a deeply entrenched set of challenges as companies develop new medical products – including declining clinical trial pat...

Non-alcoholic fatty liver disease (NAFLD) is a widespread cause of chronic liver disease (CLD) and liver-related morbidity and mortality, and is the most common cause...